MedPath

Boehringer Ingelheim USA Corporation

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website
Clinical Trials
Related News

Post Marketing Surveillance Study in Rehabilitation Clinics (Cardio, Nephro, Diabetes, Pulmo)

Completed
Conditions
Hypertension
Interventions
Drug: Micardis®
Drug: MicardisPlus®
First Posted Date
2014-10-13
Last Posted Date
2014-10-13
Lead Sponsor
Boehringer Ingelheim
Target Recruit Count
266
Registration Number
NCT02262611

Bioavailability of Increasing Pramipexole Doses of Oral Extended Release (ER) Tablets in Healthy Male Volunteers

First Posted Date
2014-10-10
Last Posted Date
2014-10-10
Lead Sponsor
Boehringer Ingelheim
Target Recruit Count
39
Registration Number
NCT02261103

Bioavailability of Different Pramipexole Slow-release Formulations Compared to Immediate-release Tablet in Healthy Male Volunteers

Phase 1
Completed
Conditions
Healthy
Interventions
Drug: Pramipexole immediate release (IR) tablets
First Posted Date
2014-10-10
Last Posted Date
2014-10-10
Lead Sponsor
Boehringer Ingelheim
Target Recruit Count
14
Registration Number
NCT02261090

Influence of Food on the Bioavailability of Telmisartan/Amlodipine Fixed Dose Combination in Healthy Japanese Male Volunteers

Phase 1
Completed
Conditions
Healthy
Interventions
Drug: Telmisartan/Amlodipine low dose
Drug: Telmisartan/Amlodipine high dose
Other: Japanese meal
First Posted Date
2014-10-10
Last Posted Date
2014-10-10
Lead Sponsor
Boehringer Ingelheim
Target Recruit Count
32
Registration Number
NCT02261064

Pharmacokinetics, Safety and Tolerability of Rising Doses of Buscopan® in Healthy Male Volunteers

Phase 1
Completed
Conditions
Healthy
Interventions
Drug: Placebo
Drug: Hyoscine butylbromide
First Posted Date
2014-10-10
Last Posted Date
2014-10-10
Lead Sponsor
Boehringer Ingelheim
Target Recruit Count
60
Registration Number
NCT02261077

Bioequivalence of Telmisartan Film-coated Tablet Compared With Two Tablets of the Conventional Telmisartan Tablet in Healthy Male Volunteers

Phase 1
Completed
Conditions
Healthy
Interventions
Drug: Telmisartan film-coated tablet
Drug: Telmisartan uncoated tablet
First Posted Date
2014-10-10
Last Posted Date
2014-10-10
Lead Sponsor
Boehringer Ingelheim
Target Recruit Count
64
Registration Number
NCT02261129

Study to Assess Potential Different Properties of Telmisartan Compared to Candesartan in Healthy Volunteers

Phase 4
Completed
Conditions
Healthy
Interventions
Drug: Candesartan
Drug: Placebo
Drug: Telmisartan
First Posted Date
2014-10-10
Last Posted Date
2014-10-10
Lead Sponsor
Boehringer Ingelheim
Target Recruit Count
24
Registration Number
NCT02261116

Relative Bioavailability of Telmisartan/Amlodipine Fixed-dose Combination Compared to Its Mono-components in Healthy Male Volunteers

Phase 1
Completed
Conditions
Healthy
Interventions
Drug: Telmisartan/amlodipine fixed-dose combination (FDC) tablet
Drug: Telmisartan
Drug: Amlodipine
First Posted Date
2014-10-09
Last Posted Date
2014-10-09
Lead Sponsor
Boehringer Ingelheim
Target Recruit Count
30
Registration Number
NCT02259803

Pharmacokinetics of Telmisartan Alone and in Combination With Amlodipine in Healthy Volunteers

Phase 1
Completed
Conditions
Healthy
Interventions
Drug: Telmisartan
Drug: Amlodipine
First Posted Date
2014-10-09
Last Posted Date
2014-10-09
Lead Sponsor
Boehringer Ingelheim
Target Recruit Count
38
Registration Number
NCT02259816

Safety, Tolerability and Pharmacokinetics of KUC 7483 CL Tablets in Healthy Male Volunteers

Phase 1
Completed
Conditions
Healthy
Interventions
Drug: KUC 7483 CL
Drug: Placebo
First Posted Date
2014-10-09
Last Posted Date
2014-10-09
Lead Sponsor
Boehringer Ingelheim
Target Recruit Count
35
Registration Number
NCT02259933
© Copyright 2025. All Rights Reserved by MedPath
HomeTerms & ConditionsPrivacy Policy